CO2022011395A2 - Polipéptidos y sus usos - Google Patents

Polipéptidos y sus usos

Info

Publication number
CO2022011395A2
CO2022011395A2 CONC2022/0011395A CO2022011395A CO2022011395A2 CO 2022011395 A2 CO2022011395 A2 CO 2022011395A2 CO 2022011395 A CO2022011395 A CO 2022011395A CO 2022011395 A2 CO2022011395 A2 CO 2022011395A2
Authority
CO
Colombia
Prior art keywords
polypeptides
nanoparticles
designing
methods
fusion proteins
Prior art date
Application number
CONC2022/0011395A
Other languages
English (en)
Spanish (es)
Inventor
Brooke Fiala
Una Nattermann
Neil P King
Carl Walkey
Jing Yang Wang
David Veesler
Alexandra C Walls
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of CO2022011395A2 publication Critical patent/CO2022011395A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/20—Protein or domain folding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50—Mutagenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Theoretical Computer Science (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
CONC2022/0011395A 2020-02-14 2022-08-12 Polipéptidos y sus usos CO2022011395A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062977036P 2020-02-14 2020-02-14
PCT/US2021/017856 WO2021163481A1 (en) 2020-02-14 2021-02-12 Polypeptides and their use

Publications (1)

Publication Number Publication Date
CO2022011395A2 true CO2022011395A2 (es) 2023-01-16

Family

ID=77292738

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2022/0011395A CO2022011395A2 (es) 2020-02-14 2022-08-12 Polipéptidos y sus usos

Country Status (10)

Country Link
US (1) US20230075095A1 (cg-RX-API-DMAC7.html)
EP (1) EP4103586A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023513592A (cg-RX-API-DMAC7.html)
KR (1) KR20220142471A (cg-RX-API-DMAC7.html)
AU (1) AU2021220958A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022016197A2 (cg-RX-API-DMAC7.html)
CL (2) CL2022002215A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022011395A2 (cg-RX-API-DMAC7.html)
PE (1) PE20230486A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021163481A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114933657B (zh) * 2021-08-25 2024-02-02 上海交通大学医学院 神经生长因子突变体重组蛋白及其应用
KR102527221B1 (ko) * 2021-10-15 2023-05-02 에스케이바이오사이언스 주식회사 단백질의 정제방법
US20250215055A1 (en) * 2022-04-07 2025-07-03 University Of Washington Secretion-optimized de novo designed protein nanoparticles for eukaryotic expression and genetic delivery
WO2024218715A1 (en) 2023-04-19 2024-10-24 Btl Healthcare Technologies A.S. Culture media based on protein hydrolysate and a process for preparing thereof
AU2024265411A1 (en) 2023-05-01 2025-11-06 University Of Washington Pre-fusion-stabilized cmv gb protein nanostructures
AR133824A1 (es) * 2023-09-15 2025-11-05 Icosavax Inc Proteínas virales y nanoestructuras y usos de estas
US12668774B2 (en) 2023-10-12 2026-06-30 Btl Healthcare Technologies A.S. Product, system and method of cell cultivation
WO2025144636A1 (en) * 2023-12-26 2025-07-03 The Scripps Research Institute ENGINEERED hMPV F PROTEIN IMMUNOGENS AND RELATED VACCINES
WO2025207938A1 (en) * 2024-03-29 2025-10-02 University Of Washington Nucleic acid vaccines against coccidioidomycosis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2568788A1 (en) * 2004-06-16 2005-12-29 Dsm Ip Assets B.V. Production of polypeptides by improved secretion
US9630994B2 (en) * 2014-11-03 2017-04-25 University Of Washington Polypeptides for use in self-assembling protein nanostructures
WO2016138525A1 (en) * 2015-02-27 2016-09-01 University Of Washington Polypeptide assemblies and methods for the production thereof
WO2016199898A1 (ja) * 2015-06-10 2016-12-15 公立大学法人 富山県立大学 活性型変異酵素の製造方法および新規活性型変異酵素、並びに可溶性化変異タンパク質の製造方法
WO2018047856A1 (ja) * 2016-09-06 2018-03-15 学校法人慶應義塾 融合タンパク質、構造体、捕集剤、捕集する方法、dna、及びベクター
US11866699B2 (en) * 2017-02-10 2024-01-09 University Of Washington Genome editing reagents and their use
EP3606942B1 (en) * 2017-04-04 2025-06-11 University of Washington Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use
CN112088014B (zh) * 2018-02-28 2026-03-24 华盛顿大学 自组装纳米结构疫苗
AU2019285048B2 (en) * 2018-06-13 2023-06-08 The Scripps Research Institute Nanoparticle vaccines with novel structural components
FR3083804B1 (fr) * 2018-07-13 2022-08-12 Institut Nat Des Sciences Appliquees De Toulouse Micro-organismes et procede pour la production d'acide glycolique a partir de pentoses et d'hexoses

Also Published As

Publication number Publication date
JP2023513592A (ja) 2023-03-31
EP4103586A1 (en) 2022-12-21
KR20220142471A (ko) 2022-10-21
PE20230486A1 (es) 2023-03-21
WO2021163481A1 (en) 2021-08-19
CL2022002215A1 (es) 2023-05-05
AU2021220958A1 (en) 2022-09-01
EP4103586A4 (en) 2024-05-15
US20230075095A1 (en) 2023-03-09
BR112022016197A2 (pt) 2022-10-25
CL2025002147A1 (es) 2026-03-06

Similar Documents

Publication Publication Date Title
CL2022002215A1 (es) Polipéptidos y sus usos
CL2021003457A1 (es) Proteínas de fusión flt3l-fc y métodos de uso
CL2024003234A1 (es) Polipéptidos modificados y usos de los mismos.
MX2018003144A (es) Dominios de superfamilia de inmunoglobulina de variante ajustable y terapia con células genéticamente modificadas.
MX2024000006A (es) Proteinas de fusion inmunomoduladoras y sus usos.
CO2019000395A2 (es) Genes de mini–distrofina optimizados y casetes de expresión y su uso
MX2023005612A (es) Celulas modificadas que expresan antigeno de membrana especifico de prostata (psma) o una forma modificada del mismo y metodos relacionados.
SV2016005264A (es) Proteínas de fusión tatk-cdkl5, composiciones, formulaciones y uso de estas
AR107078A1 (es) Anticuerpo antimiostatina, polipéptidos que contienen regiones fc variantes así como métodos de uso
PE20151774A1 (es) Construcciones de proteinas mitocondriales y sus usos
UY35416A (es) Anticuerpos humanos de la proteína f del virus respiratorio sincicial y métodos de uso de estos.
UY37341A (es) Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
CL2017001584A1 (es) Anticuerpos antimiostatina, polipéptidos que contienen regiones fc variantes, y métodos de uso
UY36370A (es) Polipéptidos fgf-21 modificados y sus usos
AR106144A1 (es) Un conjugado de proteína que comprende polipéptidos fisiológicos y una región fc inmunoglobulina
EA201791918A1 (ru) Модификация белков клеток-хозяев
AR095268A1 (es) ANTICUERPOS HUMANOS QUE SE UNEN AL FACTOR a DE LA NECROSIS (TNF-a) HUMANO Y MÉTODOS PARA PREPARARLOS
DOP2015000211A (es) Anticuerpos anti-cd52
MX377780B (es) Sobreexpresion de reguladores de la ruta de n-glicosilacion para modular la glicosilacion de proteinas recombinantes.
CL2023002272A1 (es) Anticuerpos y usos de estos
MX2018007298A (es) Variantes con mejores propiedades de polipéptidos de fusión relacionados con omega-hidroxilasa.
CL2016002239A1 (es) Medios de anclaje con cable para una junta horizontal, y procedimiento de anclaje con cable para una junta horizontal.
PE20221416A1 (es) Proteinas de fusion nkg2d y sus usos
DK3277818T3 (da) Brug af vitaminer og vitaminstofskiftegener og -proteiner til produktion af rekombinant protein i pattedyrsceller
EP4165066A4 (en) FUSION POLYPEPTIDE